A major obstacle in autism research has been the lack of objective means of measuring the effectiveness of various treatments. Over the years, researchers have published hundreds of studies attempting to evaluate different biomedical and psycho-educational interventions intended to benefit autistic children. Much of this research produced inconclusive or, worse, misleading results, because there are no useful tests or scales designed to measure treatment effectiveness. Lacking such a scale, researchers resorted to using scales such as the Childhood Autism Rating Scale (CARS), the Gilliam Autism Rating Scale (GARS), or the Autism Behavior Checklist (ABC), all of which were designed to diagnose autism- to tell whether or not a child is autistic–and not to measure treatment effectiveness.

Cell-El’s Biomarker clinical research protocol seeks to observe change in immune markers pre/post treatment. We strive to understand whether changes we observe in the biomarkers correspond to changes in ASD core symptoms and behaviors. The ATEC – designed specifically for this task – is central to our research. Parents can access the ATEC for free, online and try it out as a baseline prior to implementing therapies and as the therapy progresses. Click here to visit ATEC.